Recruiting
Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain
H0P-MC-NP01 - ClinicalTrials.gov - NCT04476108
This study is being done to test the safety and efficacy of the study drug LY3016859 for the treatment of diabetic peripheral neuropathic pain.
How long will I be in the trial?
The study will last about 26 weeks and may include up to 8 visits.
Recruiting
Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain
H0P-MC-NP01 - ClinicalTrials.gov - NCT04476108
This study is being done to test the safety and efficacy of the study drug LY3016859 for the treatment of diabetic peripheral neuropathic pain.
How long will I be in the trial?
The study will last about 26 weeks and may include up to 8 visits.
Key Requirements
Age :
18+
Sex:
All
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participants must have daily pain for at least 12 weeks
Participants must have a body mass index of <40 kilograms per meter squared (kg/m²)
Participants must be willing to maintain any non-drug pain relieving therapies (for example, physical therapy) and not start any new non drug pain-relieving therapies during the study
Participants must be willing to stop all pain medications for diabetic nerve pain, except for rescue medication allowed in the study
Participants must have type 1 or type 2 diabetes and stable glycemic control
Participants must NOT
Participants must not have surgery planned during the study for any reason
Have had cancer within 2 years, except for certain types of skin cancer (cutaneous basal cell or squamous cell carcinoma) surgically removed
Participants must not have an intolerance to acetaminophen or paracetamol
Participants must not have a history of alcohol or drug disorder within 2 years
Participants must not have a current drug-induced neuropathy, for example, due to some types of chemotherapy, or other types of peripheral neuropathy
Trial Summary
Conditions the trial is for
Diabetic Nerve Pain (Neuropathy)
What the trial is testing?
LY3016859
Could I receive a Placebo?
yes
Enrollment Goal
125
Trial Dates
July 2020 - March 2022
Trial Phase
2
Enter your postal code to find the nearest site
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participants must have daily pain for at least 12 weeks
Participants must have a body mass index of <40 kilograms per meter squared (kg/m²)
Participants must be willing to maintain any non-drug pain relieving therapies (for example, physical therapy) and not start any new non drug pain-relieving therapies during the study
Participants must be willing to stop all pain medications for diabetic nerve pain, except for rescue medication allowed in the study
Participants must have type 1 or type 2 diabetes and stable glycemic control
Participants must NOT
Participants must not have surgery planned during the study for any reason
Have had cancer within 2 years, except for certain types of skin cancer (cutaneous basal cell or squamous cell carcinoma) surgically removed
Participants must not have an intolerance to acetaminophen or paracetamol
Participants must not have a history of alcohol or drug disorder within 2 years
Participants must not have a current drug-induced neuropathy, for example, due to some types of chemotherapy, or other types of peripheral neuropathy
Trial Summary
Conditions the trial is for
Diabetic Nerve Pain (Neuropathy)
What the trial is testing?
LY3016859
Could I receive a Placebo?
yes
Enrollment Goal
125
Trial Dates
July 2020 - March 2022
Trial Phase
2
Not the right fit? Sign up to receive updates on new trials.
Trial Locations
Hide locations not currently recruiting
Diabetic Nerve Pain (Neuropathy) Resources
